TherapeuticsMD (TXMD) Non Operating Interest Expenses (2010 - 2025)
TherapeuticsMD's Non Operating Interest Expenses was $3,000 in Q3 2025, unchanged from $3,000 a year earlier and up 50.0% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Non Operating Interest Expenses (2010 - 2025) Analysis & Trends
On a trailing twelve-month basis, TherapeuticsMD's Non Operating Interest Expenses was $10,000 through Sep 30, 2025, down 86.3% year-over-year; for FY2021, it came in at $32.92 million, up 15.2% from FY2020.
- Non Operating Interest Expenses has now increased for three consecutive years, with a three-year compound annual growth rate of 91.6% (FY2018 to FY2021).
- In earlier years, Non Operating Interest Expenses was $28.58 million in FY2020 (+64.4%), $17.38 million in FY2019 (+271.6%) and $4.68 million in FY2018.
- Quarterly Non Operating Interest Expenses has moved between $2,000 (Q1 2025) and $14.41 million (Q1 2022) over five years.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q1 2021 (growth of 63.3%); the worst was Q1 2023 (a decline of 99.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.58 Bn | 1,139.17 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 645.51 Bn | 565.37 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 502.28 Bn | 475.39 Bn | 12.70 Bn | - |
| 4 | Merck | 363.81 Bn | 318.18 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.62 Bn | 266.61 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 268.13 Bn | 241.81 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 242.20 Bn | 197.60 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 193.87 Bn | 168.07 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 172.06 Bn | 118.71 Bn | 10.94 Bn | - |
| 10 | TherapeuticsMD | 21.41 Mn | 21.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Mar 31, 2022 | 14.41 Mn |
| Dec 31, 2021 | 7.58 Mn |
| Sep 30, 2021 | 7.52 Mn |
| Jun 30, 2021 | 7.60 Mn |
| Mar 31, 2021 | 10.23 Mn |
| Dec 31, 2020 | 7.61 Mn |
| Sep 30, 2020 | 7.68 Mn |
| Jun 30, 2020 | 7.03 Mn |
| Mar 31, 2020 | 6.26 Mn |
| Dec 31, 2019 | 5.66 Mn |
| Sep 30, 2019 | 5.60 Mn |
| Jun 30, 2019 | 4.03 Mn |
API Access
TherapeuticsMD Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();